Omeprazole 20 mg
Sponsors
Bayer, Janssen Research & Development, LLC, National University Hospital, Singapore, McGill University
Conditions
Crohn DiseaseDigestive HealthGastrointestinal HealthHealthyHeartburnIdiopathic Granulomatous MastitisUlcerative Colitis
Phase 1
A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy Subjects
CompletedNCT03058419
Start: 2017-03-14End: 2017-05-15Updated: 2017-06-08
Study to Assess the Relative Bioavailability of Fixed-Dose Combination (FDC) Tablet (Simeprevir, Odalasvir and AL-335) Compared With Single Agents Administered Together, and to Assess the Effect of Multiple-Dose Lansoprazole or Omeprazole on Single-Dose Pharmacokinetics of SMV, ODV, and AL-335 (FDC)
TerminatedNCT03059303
Start: 2017-02-20End: 2017-04-24Updated: 2017-12-22
A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis
TerminatedNCT03358706
Start: 2018-02-02End: 2021-11-22Updated: 2025-08-21
Phase 4
Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036)
CompletedNCT01587885
Start: 2012-01-31End: 2012-05-31Updated: 2015-03-11
Comparing Effectiveness of Steroids and Methotrexate in Treatment of Chronic Inflammatory Breast Disease
Not yet recruitingNCT06943482
Start: 2025-07-01End: 2028-02-01Target: 40Updated: 2025-04-24